Polaris Venture Management Co. V, L.L.C.'s Net Worth
$177 Million
Who is Polaris Venture Management Co. V, L.L.C.?
Polaris Venture Management Co. V, L.L.C. has an estimated net worth of $177 Million. This is based on reported shares across multiple companies, which include Phreesia, Inc., BIND Therapeutics, Inc, Adagio Therapeutics, Inc., Cardlytics, Inc., Pulmatrix, Inc., OCULAR THERAPEUTIX, INC, FATE THERAPEUTICS INC, TREVENA INC, GENOCEA BIOSCIENCES, INC., SELECTA BIOSCIENCES INC, Cerulean Pharma Inc., Lyra Therapeutics, Inc., Kala Pharmaceuticals, Inc., T2 Biosystems, Inc., aTYR PHARMA INC, Arsanis, Inc., and INTERNET BRANDS, INC..
SEC CIK
Polaris Venture Management Co. V, L.L.C.'s CIK is 0001439589
Past Insider Trading and Trends
2018 was Polaris Venture Management Co. V, L.L.C.'s most active year for acquiring shares with 54 total transactions. Polaris Venture Management Co. V, L.L.C.'s most active month to acquire stocks was the month of January. 2015 was Polaris Venture Management Co. V, L.L.C.'s most active year for disposing of shares, totalling 128 transactions. Polaris Venture Management Co. V, L.L.C.'s most active month to dispose stocks was the month of June. 2014 saw Polaris Venture Management Co. V, L.L.C. paying a total of $16,944,749.00 for 14,682,469 shares, this is the most they've acquired in one year. In 2015 Polaris Venture Management Co. V, L.L.C. cashed out on 15,642,290 shares for a total of $21,694,891.32, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Phreesia, Inc. (PHR) Snapshot price: $26.88
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -10.00% | -357.12K |
$24.48 | -$8,741,964.95 | 3.21M |
Dec 17
| |||
Form 4
|
∞
| 3.57M |
$18.00 | -$7,142,382.00 | 3.57M |
Jul 22
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
BIND Therapeutics, Inc No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 2.02M |
$15.00 |
—
| 2.02M |
Sep 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Adagio Therapeutics, Inc. (IVVD) Snapshot price: $4.75
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Cardlytics, Inc. (CDLX) Snapshot price: $6.56
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -2.96% | -68.73K |
$27.65 | -$1,900,767.37 | 2.25M |
Scheduled
|
Jul 15 - Jul 17
| ||
Form 4
| -4.21% | -100.00K |
$25.62 | -$2,562,120.00 | 2.28M |
Jun 7
| |||
Form 4
| -3.07% | -75.28K |
$24.09 | -$1,814,073.25 | 2.38M |
Jun 4 - Jun 6
| |||
Form 4
| -3.92% | -100.00K |
$23.04 | -$2,303,810.00 | 2.45M |
May 28
| |||
Form 4
| -5.55% | -150.00K |
$25.04 | -$3,756,280.86 | 2.55M |
Sep 12 - Sep 13
| |||
Form 4
| +2.52% | 66.36K |
—
| $26.56 | 2.7M |
Aug 7 - Aug 9
| |||
Form 4
| +22.06% | 2.64M |
—
|
—
| 14.59M |
Feb 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Pulmatrix, Inc. (PULM) Snapshot price: $1.8
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +28.53% | 1.15M |
—
|
—
| 5.18M |
Apr 3
| |||
Form 4/A
| +2.72% | 74.04K |
$6.88 | $508,997.51 | 2.8M |
Jun 15
| |||
Form 4
| +7,856.20% | 4.03M |
$6.88 | $9,570.00 | 4.08M |
Jun 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |